1 asset in TNF Receptor 1-Associated Periodic Fever Syndrome

Therapeutic assets addressing TNF Receptor 1-Associated Periodic Fever Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region) TNF Receptor 1-Associated Periodic Fever Syndrome	Novartis Pharmaceuticals	P2	CCC (54)